Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Intransit Stage III/IV Melanoma”

2 trials

Showing 2 of 2 results

Not applicableEnded earlyNCT02716077
What this trial is testing

Early FDG PET in Melanoma

Who this might be right for
Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
Abramson Cancer Center at Penn Medicine 6
Early research (Phase 1)Study completedNCT01213732
What this trial is testing

Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma

Who this might be right for
Patients With Intransit Stage III/IV Melanoma
Philogen S.p.A. 19

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation